François Bompart
Inserm(FR)Committee on Publication Ethics(GB)
Publications by Year
Research Areas
Ethics in Clinical Research, COVID-19 Clinical Research Studies, Biomedical Ethics and Regulation, Long-Term Effects of COVID-19, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium(1999)220 cited
- → Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/Dalfopristin(2001)92 cited
- → COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study(2021)80 cited
- → Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives(2020)76 cited
- → Prospective, Randomized Dose-Ranging Open Phase II Pilot Study of Quinupristin/Dalfopristin versus Vancomycin in the Treatment of Catheter-Related Staphylococcal Bacteremia(1999)51 cited
- → Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience(2011)45 cited